Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients With IRon Deficiency and Chronic Heart Failure

NCT03036462 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT03036462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03036462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients With IRon Deficiency and Chronic Heart Failure
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Phase 4
Overall status
Completed
Start date
March 7, 2017
Completion date
May 2, 2024
Enrollment
1,105 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency, systolic heart failure